|
1
|
Ohgaki H: Epidemiology of brain tumors.
Methods Mol Biol. 472:323–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Sarkar S, Cua R, Zhou Y, Hader W
and Yong VW: A dialog between glioma and microglia that promotes
tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
Carcinogenesis. 33:312–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deshmane SL, Kremlev S, Amini S and Sawaya
BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J
Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoshimura T, Yuhki N, Moore SK, Appella E,
Lerman MI and Leonard EJ: Human monocyte chemoattractant protein-1
(MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated
blood mononuclear leukocytes, and sequence similarity to mouse
competence gene JE. FEBS Lett. 244:487–493. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dagouassat M, Suffee N, Hlawaty H, Haddad
O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO,
Gattegno L, et al: Monocyte chemoattractant protein-1 (MCP-1)/CCL2
secreted by hepatic myofibroblasts promotes migration and invasion
of human hepatoma cells. Int J Cancer. 126:1095–1098.
2010.PubMed/NCBI
|
|
6
|
Cho YA and Kim J: Association of
polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer:
A meta-analysis. Cytokine. 64:213–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Horuk R: Chemokines.
ScientificWorldJournal. 7:224–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nyberg P, Salo T and Kalluri R: Tumor
microenvironment and angiogenesis. Front Biosci. 13:6537–6553.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kruizinga RC, Bestebroer J, Berghuis P, de
Haas CJ, Links TP, de Vries EG and Walenkamp AM: Role of chemokines
and their receptors in cancer. Curr Pharm Des. 15:3396–3416. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang D, Wang H, Brown J, Daikoku T, Ning
W, Shi Q, Richmond A, Strieter R, Dey SK and DuBois RN: CXCL1
induced by prostaglandin E2 promotes angiogenesis in colorectal
cancer. J Exp Med. 203:941–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balentien E, Mufson BE, Shattuck RL,
Derynck R and Richmond A: Effects of MGSA/GRO alpha on melanocyte
transformation. Oncogene. 6:1115–1124. 1991.PubMed/NCBI
|
|
13
|
Haghnegahdar H, Du J, Wang D, Strieter RM,
Burdick MD, Nanney LB, Cardwell N, Luan J, Shattuck-Brandt R and
Richmond A: The tumorigenic and angiogenic effects of MGSA/GRO
proteins in melanoma. J Leukoc Biol. 67:53–62. 2000.PubMed/NCBI
|
|
14
|
Zhou Y, Zhang J, Liu Q, Bell R, Muruve DA,
Forsyth P, Arcellana-Panlilio M, Robbins S and Yong VW: The
chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to
glioma cells. Carcinogenesis. 26:2058–2068. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Di Cesare S, Marshall JC, Logan P, Antecka
E, Faingold D, Maloney SC and Burnier MN Jr: Expression and
migratory analysis of 5 human uveal melanoma cell lines for CXCL12,
CXCL8, CXCL1, and HGF. J Carcinog. 6:22007.PubMed/NCBI
|
|
16
|
Pham K, Luo D, Liu C and Harrison JK:
CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell
infiltration and survival rates are not dependent on individual
expression of either CCR1 or CCR5. J Neuroimmunol. 246:10–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Owen JD, Strieter R, Burdick M,
Haghnegahdar H, Nanney L, Shattuck-Brandt R and Richmond A:
Enhanced tumor-forming capacity for immortalized melanocytes
expressing melanoma growth stimulatory activity/growth-regulated
cytokine beta and gamma proteins. Int J Cancer. 73:94–103. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyake M, Goodison S, Urquidi V, Giacoia E
Gomes and Rosser CJ: Expression of CXCL1 in human endothelial cells
induces angiogenesis through the CXCR2 receptor and the ERK1/2 and
EGF pathways. Lab Invest. 93:768–778. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuroda T, Kitadai Y, Tanaka S, Yang X,
Mukaida N, Yoshihara M and Chayama K: Monocyte chemoattractant
protein-1 transfection induces angiogenesis and tumorigenesis of
gastric carcinoma in nude mice via macrophage recruitment. Clin
Cancer Res. 11:7629–7636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Urushihara M, Ohashi N, Miyata K, Satou R,
Acres OW and Kobori H: Addition of angiotensin II type 1 receptor
blocker to CCR2 antagonist markedly attenuates crescentic
glomerulonephritis. Hypertension. 57:586–593. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Futagami S, Tatsuguchi A, Hiratsuka T,
Shindo T, Horie A, Hamamoto T, Ueki N, Kusunoki M, Miyake K, Gudis
K, et al: Monocyte chemoattractant protein 1 and CD40 ligation have
a synergistic effect on vascular endothelial growth factor
production through cyclooxygenase 2 upregulation in gastric cancer.
J Gastroenterol. 43:216–224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saji H, Koike M, Yamori T, Saji S, Seiki
M, Matsushima K and Toi M: Significant correlation of monocyte
chemoattractant protein-1 expression with neovascularization and
progression of breast carcinoma. Cancer. 92:1085–1091. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rafei M, Deng J, Boivin MN, Williams P,
Matulis SM, Yuan S, Birman E, Forner K, Yuan L, Castellino C, et
al: A MCP1 fusokine with CCR2-specific tumoricidal activity. Mol
Cancer. 10:1212011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: A family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang CH and Tsai CC: CCL2 increases MMP-9
expression and cell motility in human chondrosarcoma cells via the
Ras/Raf/MEK/ERK/NF-κB signaling pathway. Biochem Pharmacol.
83:335–344. 2012. View Article : Google Scholar : PubMed/NCBI
|
